This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory death investigation

FBI Probes Jim Irsay Death

Analysis based on 9 articles · First reported Jan 22, 2026 · Last updated Jan 23, 2026

Sentiment
-20
Attention
4
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The investigation into Jim Irsay's death, particularly concerning the prescription of Ketamine and Opioid by Harry Haroutunian, could lead to increased scrutiny and potential regulatory changes in the pharmaceutical and addiction treatment industries. This event may also negatively impact the reputation of the United States — Indianapolis, although they have not been directly implicated in any wrongdoing.

Sports Pharmaceuticals

The United States — Federal Bureau of Investigation has launched an investigation into the death of former United States — Indianapolis owner Jim Irsay, who died in May at 65. The probe focuses on the circumstances surrounding his death, his substance use, and his relationship with addiction recovery specialist Harry Haroutunian. Haroutunian, who was treating Jim Irsay with Ketamine and Opioid, signed Jim Irsay's death certificate, listing cardiac arrest due to pneumonia and heart issues as the cause, with no autopsy performed. Reports indicate that Jim Irsay received alarming amounts of prescription drugs from Harry Haroutunian, leading to overdoses in late 2023. The United States — Indianapolis are aware of the investigation but have not been contacted directly. The United States — Drug Enforcement Administration is assisting the United States — Federal Bureau of Investigation in the inquiry. The case draws parallels to the death of Matthew Perry, also linked to Ketamine.

per
Jim Irsay's death is the central subject of the FBI investigation, with questions surrounding the circumstances of his passing and the medical treatment he received.
Importance 100.0 Sentiment -50.0
per
Harry Haroutunian, an addiction recovery specialist, is a key subject of the FBI probe, as he was treating Jim Irsay with ketamine and opioids before his death and signed his death certificate.
Importance 95.0 Sentiment -80.0
oth
Opioid pills were prescribed to Jim Irsay by Harry Haroutunian in amounts that alarmed those close to him, contributing to concerns about his treatment and subsequent death.
Importance 50.0 Sentiment -40.0
per
Matthew Perry's death, also linked to ketamine, is referenced as a high-profile case that highlights the risks associated with the drug, drawing parallels to Jim Irsay's situation.
Importance 30.0 Sentiment -60.0
govactor
loc
Importance 0.0 Sentiment 0.0
govactor
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.